REG-Alvotech further strengthens liquidity by securing term loan facility of $75 million
Alvotech has amended its credit agreement to secure a $75 million term loan facility led by GoldenTree Asset Management, maturing on December 31, 2027, with a 12.50% interest rate. This financing follows a recent $165 million equity raise, bringing the company's total access to new capital to $240 million to support its biosimilar pipeline and global product launches.
Key figures
- Interest rate
- 12.50%
- Maturity date
- December 31, 2027
- Term loan amount
- $75 million
- Recent equity raise
- $165 million
- Total new capital access
- $240 million
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.